Early therapy versus late intervention: What works?

Strategies to treat vulnerable plaques

The Netherlands The role of bile acids in cholesterol homeostasis

Neoatherosclerosis from a pathologist's point of view

Familial chylomicronemia syndrome

Familial hypercholesterolemia

Will inhibiting of thrombus formation prevent acute coronary syndromes?

Disturbances in hepatic and lipoprotein metabolism is the hallmark of atherogenic dyslipidaemia

Lifestyle and genetics an interaction contributing to CV risk

The latest practical considerations in treating blood cholesterol levels in coronary patients - State of the art lipid lowering combination therapies

Should the main target behyperglycaemia or should we focus on other risk-factors?

Stress, behavior and cardiovascular disease

Is there need to revise goals from lipid lowering?

High-resolution lipoprotein phenotypes and cardiovascular outcomes

Cardioprotection in type 2 diabetes: is the picture clear or not?

Anti-inflammatory therapy and resolution of inflammation, theory and practice